Incidence of Autoimmunity in Patients (pts) with Low-Risk (LR) Myelodysplastic Syndrome (MDS): 10 Years Follow-up

被引：2
|
作者：
Elkhanany, Ahmed [1 ]
Hanson, Curtis A. [1 ]
Patnaik, Mrinal [1 ]
Elliott, Michelle [1 ]
Litzow, Mark [1 ]
Al-Kali, Aref [1 ]
机构：
[1] Mayo Clin, Div Hematopathol, Rochester, MN USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4931.4931
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4931
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EXTENDED CYTOGENETIC FOLLOW-UP OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
    WHITE, AD
    CULLIGAN, DJ
    HOY, TG
    JACOBS, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (04) : 499 - 502
  • [2] Treatment of myelodysplastic syndrome (MDS) with cytokine immunotherapy for low-risk MDS
    Kadia, Tapan M.
    Kantadian, Hagop
    Verstovsek, Srdan
    Newman, Beth
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    BLOOD, 2007, 110 (11) : 438A - 438A
  • [3] The Population Based Incidence of Myelodysplastic Syndrome (MDS): Utility of Multiple Data Sources and Follow-up
    Kumar, Rajat
    Musuka, Charles
    Khair, Humaira
    Seftel, Matthew D.
    Szwajcer, David
    Clague, Cheryl
    Noonan, Gail
    Demers, Alain
    BLOOD, 2009, 114 (22) : 105 - 105
  • [4] Evaluation of Red Blood Cell Metabolism in Patients with Low-Risk Myelodysplastic Syndrome (LR-MDS): A Proof-ofConcept Study
    Fattizzo, Bruno
    Vercellati, Cristina
    Marcello, Anna
    Bortolotti, Marta
    Zaninoni, Anna
    Fermo, Elisa
    Bianchi, Paola
    Barcellini, Wilma
    BLOOD, 2022, 140 : 4016 - 4017
  • [5] Effect of Romiplostim in Patients (pts) with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Azacytidine
    Kantarjian, Hagop
    Giles, Frank
    Greenberg, Peter
    Paquette, Ronald
    Wang, Eunice
    Gabrilove, Janice
    Garcia-Mancro, Guillermo
    Gray, Julie
    Hu, Kuolung
    Franklin, Janet
    BLOOD, 2008, 112 (11) : 89 - 90
  • [6] Treatment and follow-up of low-risk patients with thyroid cancer
    Schlumberger, Martin
    Borget, Isabelle
    Nascimento, Camila
    Brassard, Maryse
    Leboulleux, Sophie
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (10) : 625 - 628
  • [7] Treatment and follow-up of low-risk patients with thyroid cancer
    Martin Schlumberger
    Isabelle Borget
    Camila Nascimento
    Maryse Brassard
    Sophie Leboulleux
    Nature Reviews Endocrinology, 2011, 7 : 625 - 628
  • [8] Follow-up in patients with low-risk cutaneous melanoma: is it worth it?
    Leiter, Ulrike
    Eigentler, Thomas
    Garbe, Claus
    MELANOMA MANAGEMENT, 2014, 1 (02) : 115 - 125
  • [9] Low-risk myelodysplastic syndrome managed with an erythroid-stimulating agent for 10 years
    Esparza, Anthony
    Singaraju, Raj Chandra
    Happel, Joseph Paul
    BMJ CASE REPORTS, 2020, 13 (04)
  • [10] Transfusion-dependent low-risk myelodysplastic patients receiving deferasirox: Long-term follow-up
    Improta, Salvatore
    Villa, Maria Rosaria
    Volpe, Antonio
    Lombardi, Angela
    Stiuso, Paola
    Cantore, Nicola
    Mastrullo, Lucia
    ONCOLOGY LETTERS, 2013, 6 (06) : 1774 - 1778
12345